Pan, M., Wright, W. C., Chapple, R. H., Zubair, A., Sandhu, M., Batchelder, J. E., . . . Geeleher, P. (2021). The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma. Nature Portfolio.
Chicago Style (17th ed.) CitationPan, Min, et al. The Chemotherapeutic CX-5461 Primarily Targets TOP2B and Exhibits Selective Activity in High-risk Neuroblastoma. Nature Portfolio, 2021.
MLA (8th ed.) CitationPan, Min, et al. The Chemotherapeutic CX-5461 Primarily Targets TOP2B and Exhibits Selective Activity in High-risk Neuroblastoma. Nature Portfolio, 2021.
Warning: These citations may not always be 100% accurate.